Nafcillin
Nafcillin for Injection, USP
Approved
Approval ID
c39721a3-7b22-4720-9dbd-bc82f03d2af7
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 17, 2019
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
NAFCILLIN SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-327
Application NumberANDA090002
Product Classification
M
Marketing Category
C73584
G
Generic Name
NAFCILLIN SODIUM
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 17, 2019
FDA Product Classification
INGREDIENTS (2)
SODIUM CITRATEInactive
Quantity: 40 mg in 4 mL
Code: 1Q73Q2JULR
Classification: IACT
NAFCILLIN SODIUMActive
Quantity: 1 g in 4 mL
Code: 49G3001BCK
Classification: ACTIM
NAFCILLIN SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-328
Application NumberANDA090002
Product Classification
M
Marketing Category
C73584
G
Generic Name
NAFCILLIN SODIUM
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMay 17, 2019
FDA Product Classification
INGREDIENTS (2)
SODIUM CITRATEInactive
Quantity: 40 mg in 8 mL
Code: 1Q73Q2JULR
Classification: IACT
NAFCILLIN SODIUMActive
Quantity: 2 g in 8 mL
Code: 49G3001BCK
Classification: ACTIM